Fact CheckerSign in

NCT06733064Active, not recruiting

Strenght Training in Osteoporosis Prevention

Effective Prevention of Osteoporosis Through Rehabilitation and Training

Source: ClinicalTrials.gov · Last updated 13 Dec 2024

Brief summary (registry, in English)

The study involves 120 women over the age of 50. All participants in the study take part in high-intensity strength training for 10 months. In addition, half of the participants receive vitamin D3 at a dose of 4,000 IU/day. The investigators hypothesize that training combined with vitamin D3 supplementation will be more effective in preventing osteoporosis than training alone.

Status (registry)
Active, not recruiting
Study type
Interventional
Enrollment
120 (actual)
First submitted
8 Nov 2024
Start date
2 Sept 2024
Primary completion date
30 Oct 2024
Lead sponsor
Mateusz Karnia
Diseases
Osteoporosis
NCT number
NCT06733064

What you commit to

  • Study type: Interventional
  • Participants enrolled: 120
  • From 2 Sept 2024 to the primary completion date, 30 Oct 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • ongoing cancer,
  • unstabilized cardiovascular disease,
  • cognitive disorders,
  • diseases affecting the skeleton such as: Paget's disease, type I diabetes mellitus,
  • taking medications affecting skeletal conditions including: long-term therapy with corticosteroids, thiazides, antiretroviral drugs,

Other

  • radiological treatment in the last 12 months,
  • other contraindications to undertaking high-intensity strength training,
  • contraindications to taking vitamin D including: hypercalcemia, nephrolithiasis, sarcoidosis, lack of cholecalciferol hydroxylase activity in the liver and kidneys.

Who the study is looking for

  • age over 50
  • female

Age in the registry: 50 years to - · Sex: Female · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University of Gdańsk, Faculty of Biology
Coordinator of this site? Confirm its status
GdanskPolandUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.